NAV Growth
Growth of each fund's NAV over the selected period, rebased to 0%
-
-
-
1M
3M
6M
1Y
3Y
5Y
Fund Details
| Fund Details | HDFC Pharma and Healthcare Fund - Direct (G) |
|---|---|
| Fund Type | Equity |
| Risk | Very High |
| Min SIP Amount | ₹100 |
| Min Lumpsum | ₹100 |
| Expense Ratio | 1.08% |
| NAV | ₹22.61 (25 Sept 2026) |
| Fund Size | ₹3,310.64 Cr |
| Fund Started | 04 Oct 2023 |
| Lock-in Period | No lock-in |
| Exit Load | In respect of each purchase/Switch-in of units, an Exit load of 1% is payable if units are redeemed/switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 30 days from the date of allotment. |
Returns
| Returns | HDFC Pharma and Healthcare Fund - Direct (G) |
|---|---|
| 1M | 2.74% |
| 3M | 9.11% |
| 6M | 30.24% |
| 1Y | 28.36% |
| 3Y | — |
| 5Y | — |
| Since Inception | 31.73% |
Risk Ratios
Trailing risk-adjusted performance measures
| Risk Ratio | HDFC Pharma and Healthcare Fund - Direct (G) |
|---|---|
| Alpha | 24.17 |
| Beta | 0.66 |
| Sharpe | 1.58 |
| Standard Deviation | 4.68 |
Holding Analysis
| Holding Analysis | HDFC Pharma and Healthcare Fund - Direct (G) |
|---|---|
| Top 5 Holdings | 30.66% |
| Top 10 Holdings | 48.86% |
| Portfolio Turnover | 34.76 |
| Equity | 98.42% |
| Debt | 1.83% |
| Cash | — |
Top Holdings
HDFC Pharma and Healthcare Fund - Direct (G)
Fund Manager
| Fund Manager | HDFC Pharma and Healthcare Fund - Direct (G) |
|---|---|
| Name | , |
About Fund
| About | HDFC Pharma and Healthcare Fund - Direct (G) |
|---|---|
| AMC | HDFC Mutual Fund |
| Scheme Category | Sectoral Fund |
| Benchmark | BSE Healthcare TRI |
| Launch Date | 14 Sept 2023 |

